- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04391660
Estimation of the Incidence of Colonization of Peripheral Venous Catheters After Skin Disinfection With 0.5% Sodium Hypochlorite, Preceded or Not by an Application of 70% Ethanol (DACLEAN)
Estimation of the Incidence of Colonization of Peripheral Venous Catheters After Skin Disinfection With 0.5% Sodium Hypochlorite, Preceded or Not by an Application of 70% Ethanol: Pilot, Monocentric, Randomized, Open-label Study
The peripheral venous catheter is the most commonly used medical device in the hospital setting. Infectious complications are infrequent, bacterial or fungal, and local or systemic (catheter-related bacteremia). The latter prolong the length of hospitalization and increase the cost of care and mortality. For peripheral venous catheters, the risk of catheter-related bacteremia is lower (0.2-0.7 episodes per 1000 catheter days) than for other intravascular devices. However, the much higher number of peripheral venous catheters used explains a total number of infections close to that of other catheters. Colonization is usually the preliminary step to catheter infection. It is far more common than infection. Skin disinfection prior to catheter insertion is therefore essential to prevent this complication.
Currently, Chlorhexidine or Povidone Iodine in alcoholic solution is recommended before insertion of a peripheral venous catheter. Although rare, allergies may contraindicate these antiseptics. The widespread use of antiseptics in recent years for hand disinfection, mouthwashes or body baths could increase the risk of the development of strains that have become less sensitive, or even resistant, to currently available antiseptics. Allergies and reduced sensitivity require the search for alternatives to currently available solutions. Sodium hypochlorite is used to disinfect mucous membranes or healthy skin before an invasive procedure in children under 30 months of age. Very few studies have evaluated its efficacy in adults for this same indication, despite the fact that it was the first antiseptic used to prevent infections.
The aim of this study is to estimate the colonization rate of peripheral venous catheters after skin disinfection with 0.5% sodium hypochlorite (Dakin®) alone or preceded by an application of 70% ethanol.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Poitiers, France, 86021
- University Hospital of Poitiers
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patient (≥18 years old) requiring hospitalization in participating services
- Having an indication for the placement of a peripheral venous catheter for an expected duration of at least 48 hours
- Free subject, without guardianship or curatorship or subordination
- A person affiliated to or benefiting from a social security scheme.
- Having given free and informed consent
Exclusion Criteria:
- Hypersensitivity to any of the constituents of Dakin® and/or Cooper® modified alcohol;
- History of epilepsy,
- Placement of a peripheral venous catheter in the emergency room that does not allow the usual rules of hygiene to be respected;
- Difficult vascular access foreseeable (drug addict, obese, non-visible veins...);
- Participation in another research protocol reducing the risk of catheter-related infection;
- Patient having received an antibiotic treatment in the 15 days prior to inclusion in the study;
- Patient who has already participated in the study;
- Subjects not affiliated with a Social Security system.
- Subjects benefiting from enhanced protection, namely persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection (guardianship and trusteeship) and finally patients in emergency situations.
- Pregnant or breastfeeding women, women of child-bearing age who do not have effective contraception (hormonal/mechanical: per os, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy...).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: 0.5% sodium hypochlorite solution
|
Disinfection with a 0.5% sodium hypochlorite solution applied with a sterile compress.
This same antiseptic will be used at each dressing change.
|
ACTIVE_COMPARATOR: 0.5% sodium hypochlorite solution and 70% ethanol
|
Disinfection with a 0.5% sodium hypochlorite solution applied with a sterile compress preceded by an application of 70% ethanol with a sterile compress, for its immediate bactericidal action.
0.5% sodium hypochlorite solution will be applied once the alcohol has evaporated and the skin is visually dried.
These same antiseptics will be used at each dressing change.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Incidence of colonized catheters
Time Frame: Up to 14 days
|
Up to 14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Local infection, defined as colonization of the catheter or purulent discharge at the insertion site with a positive culture or no culture at the insertion site (a negative culture, in the absence of antibiotics, eliminates the case)
Time Frame: Up to 14 days
|
Up to 14 days
|
|
General infection, defined as colonization of the catheter in the presence of general signs of infection and total or partial regression of these signs within 48 hours after catheter removal
Time Frame: Up to 16 days
|
General infection, defined as colonization of the catheter in the presence of general signs of infection (fever > 38.5° or hypothermia < 36°, chills, hypotension with PAS < 90 mmHg) and total or partial regression of these signs within 48 hours after catheter removal
|
Up to 16 days
|
Catheter-related bacteremia/fungemia
Time Frame: Up to 14 days
|
Up to 14 days
|
|
Incidence of a positive catheter culture regardless of the threshold and the microorganism under consideration
Time Frame: Up to 14 days
|
Up to 14 days
|
|
Incidence of local skin reaction and its severity
Time Frame: Up to 14 days
|
Up to 14 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DACLEAN
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Disinfection Before Peripheral Venous Catheter Insertion
-
Seoul National University HospitalCompletedInsertion Depth of Central Venous Catheter
-
RenJi HospitalCompletedInsertion Depth of Central Venous CatheterChina
-
The First Affiliated Hospital of Zhengzhou UniversityCompletedShort Peripheral Venous CatheterChina
-
Joseph D. TobiasCompletedCentral Venous Catheter | Arterial Access | Peripheral AccessUnited States
-
William Beaumont HospitalsCompletedVascular Access Complication | IV Catheter-Related Infection or Complication | Peripheral Venous AccessUnited States
-
William Beaumont HospitalsTeleflexCompletedCatheter Infection | Catheter Complications | Catheter ThrombosisUnited States
-
University of California, San DiegoCompletedBreast Cancer | Mastectomy | Paravertebral Catheter InsertionUnited States
-
IRCCS Policlinico S. MatteoCompletedPhlebitis | Occlusion | Ecchymosis | Peripheral Venous Catheter ComplicationsItaly
-
Instituto de Investigacion Sanitaria La FeWithdrawnSepsis Affecting Skin | Central Venous Catheter Related Bacteremia
-
Washington University School of MedicineMassachusetts General Hospital; Ontario Clinical Oncology Group (OCOG); St. Luke...RecruitingDeep Vein Thrombosis | Post Thrombotic Syndrome | Venous Insufficiency | Venous Leg Ulcer | Venous Stasis | Venous RefluxUnited States
Clinical Trials on 0.5% sodium hypochlorite solution
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento...Completed
-
Vastra Gotaland RegionRecruitingDiabetic Foot UlcerSweden
-
Association of Paediatric and Preventive Dentists...CompletedTeeth, Endodontically-TreatedSerbia
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedProstheses-related Infections
-
Northwestern UniversityTerminatedRadiation DermatitisUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedHead and Neck Carcinoma | Radiation-Induced DermatitisUnited States
-
University of RochesterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompleted
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityCompleted
-
Damascus UniversityCompletedDental Caries | Infection, Bacterial | Tooth, DeciduousSyrian Arab Republic